There has been a rush within the past few years towards natural plants and berries that have high anti-oxidation properties. Why the rush? Usually, these rushes to the “flavor of the day” are usually more because of well timed, well placed advertising media than for strong double blind “New England Journal of Medicine” type reasons.
In the case of a few products however, like Resveratrol and Acai Berry there seems to be a few who disagree as to the potential usefulness of the product, a few who are neutral and a great many whom agree that the product is useful but whom want to wait for further tests in order to throw their weight behind it.
Alka-V6/Alkav6 formerly known as AlkaVita, is one of those lesser known products that appears to have so many health benefits that it risks being labelled snake oil by the masses. In a nutshell, Alkavita is basically pure water with a PH Balance that is stratospheric. Where your blood should be more or less neutral at approximately 7, 0 is extreme acidic, and extreme alkalinity is measured at above 14. Alkavita has an incredible but legal Alkaline Ph of 14.3.
So, why is this beneficial to us? Primarily because nearly every meat, soft drink and many other products adds to our acidic level. Our blood must stay at a neutral 7 so the body hustles the extra acid off to other areas of the body until it can either dissipate it or get rid of it.
It is thought that the types of symptoms caused by this storage of higher acidic material in joints and other places around the body can mimic arthritis at a minimum and in other cases auto-immune type diseases that a poor doctor has no possible way of treating in a 1 hour visit.
Alka-V6 concentrate is intended to make 1 gallon of alkaline water that the body will use to heal itself and maintain your health and energy. The nature of the modified liquid silicon allows the body to absorb the water easier and most diseases cannot survive or multiply in an alkaline environment. Skin is able to absorb water more easily and so makes wrinkles less noticeable. There are no preservatives added.
You have more energy as your body has more oxygen in it, and your quality of life simply rises.Watching what you eat is still urgent. This is not a miracle potion, it is a safe product, mineral, that will increase your body’s alkalinity and help accelerate the natural healing process we all enjoyed when we were young.
Alka-V6 is also a natural antibiotic so it will help heal cuts, bites, scratches and itches in a healthy and natural way.
Alkavita will not interfere with any medications, often it enhances the medications.Diabetics should monitor their sugar levels when taking AlkaVita because it will often decrease the need for insulin.
The power of Alkaline Water! Texas State University is about to release results of a study that could mean a new way to fight cancer. Don’t run out and buy alkaline water yet, this testing was done in vitrio and with alka-v6/alkav6 only.
News 8’s Todd Boatwright has more on the two Texas State researchers’ findings.
The news comes as the number of breast cancer patients in Central Texas alone is expected to reach 900 this year.
Dr. Dhiraj Vattem, a professor in the Department of Family and Consumer Sciences, and Texas State Department of Agriculture Chair Dr. Reed Richardson co-investigated the new compound.
“We have a product we’ve been testing in the laboratory. All we’ve done so far is in vitro testing, which is artificial settings outside the organism,” Dr. Richardson said. “It is a compound that looks very effective in changing some of the metabolic pathways that are responsible for the cancer to either attach or grow.”
Dr. Richardson said that with the particular compound (alkav6) they have been testing, results were very consistent.
“It’s a silicon-based compound, and we use this at different levels to test these different systems, within cancer cells, as well as the HIV virus,” Dr. Richardson said. “We got real promise and results from that.”
Texas State researchers and Orizon Research Institute will present their current findings in a press conference at 2 p.m. Wednesday on the second floor of the Agricultural Building on the Texas State Campus.
For cancer, in vitro tests, the compound (alkav6) prevented cancerous cells from attaching to other cells, which slows down cancerous cells’ growth rate, Dr. Richardson said. The compound also reduced harmful mutations in the DNA and increased the likelihood of apoptosis, or programmed cell death. Finally the compound stimulated anti-oxidant enzymes responsible for some of the metabolic pathways.
“We measured a lot of different things in vitro, but they all got nice responses from the standpoint of pointing us toward a direction for a mode of action on this product,” he said. “It’s very important to say, that second phase, where we go in vivo, inside organisms within organisms’ systems, is the definitive step.”
The data from the in vivo studies is expected to be published later this year.
LONDON (Reuters) – A molecule found in a curry ingredient can kill esophageal cancer cells in the laboratory, suggesting it might be developed as an anti-cancer treatment, scientists said on Wednesday.
Researchers at the Cork Cancer Research Center in Ireland treated esophageal cancer cells with curcumin — a chemical found in the spice turmeric, which gives curries a distinctive yellow color — and found it started to kill cancer cells within 24 hours.
The cells also began to digest themselves, they said in a study published in the British Journal of Cancer.
Previous scientific studies have suggested curcumin can suppress tumors and that people who eat lots of curry may be less prone to the disease, although curcumin loses its anti-cancer attributes quickly when ingested.
But Sharon McKenna, lead author of the Irish study, said her study suggested a potential for scientists to develop curcumin as an anti-cancer drug to treat esophageal cancer.
Cancers of the esophagus kill more than 500,000 people across the world each year. The tumors are especially deadly, with five-year survival rates of just 12 to 31 percent.
McKenna said the study showed curcumin caused the cancer cells to die “using an unexpected system of cell messages.”
Normally, faulty cells die by committing programed suicide, or apoptosis, which occurs when proteins called caspases are ’switched on’ in cells, the researchers said.
But these cells showed no evidence of suicide, and the addition of a molecule that inhibits caspases and stops this “switch being flicked’ made no difference to the number of cells that died, suggesting curcumin attacked the cancer cells using an alternative cell signaling system.
U.S. researchers said in 2007 they had found curcumin may help stimulate immune system cells in the Alzheimer’s disease.
Call it the arrow of cancer. Like the arrow of time, it was supposed to point in one direction. Cancers grew and worsened.
Cancer Society, in Shift, Has Concerns on Screenings (October 21, 2009)
Health Guide: Cancer
But as a paper in The Journal of the American Medical Association noted last week, data from more than two decades of screening for breast and prostate cancer call that view into question. Besides finding tumors that would be lethal if left untreated, screening appears to be finding many small tumors that would not be a problem if they were left alone, undiscovered by screening. They were destined to stop growing on their own or shrink, or even, at least in the case of some breast cancers, disappear.
“The old view is that cancer is a linear process,” said Dr. Barnett Kramer, associate director for disease prevention at the National Institutes of Health. “A cell acquired a mutation, and little by little it acquired more and more mutations. Mutations are not supposed to revert spontaneously.”
So, Dr. Kramer said, the image was “an arrow that moved in one direction.” But now, he added, it is becoming increasingly clear that cancers require more than mutations to progress. They need the cooperation of surrounding cells and even, he said, “the whole organism, the person,” whose immune system or hormone levels, for example, can squelch or fuel a tumor.
Cancer, Dr. Kramer said, is a dynamic process.
It was a view that was hard for some cancer doctors and researchers to accept. But some of the skeptics have changed their minds and decided that, contrary as it seems to everything they had thought, cancers can disappear on their own.
“At the end of the day, I’m not sure how certain I am about this, but I do believe it,” said Dr. Robert M. Kaplan, the chairman of the department of health services at the School of Public Health at the University of California, Los Angeles, adding, “The weight of the evidence suggests that there is reason to believe.”
Disappearing tumors are well known in testicular cancer. Dr. Jonathan Epstein at Johns Hopkins says it does not happen often, but it happens.
A young man may have a lump in his testicle, but when doctors remove the organ all they find is a big scar. The tumor that was there is gone. Or, they see a large scar and a tiny tumor because more than 95 percent of the tumor had disappeared on its own by the time the testicle was removed.
Or a young man will show up with a big tumor near his kidney. Doctors realize that it started somewhere else, so they look for its origin. Then they discover a scar in the man’s testicle, the only remnant of the original cancer because no tumor is left.
Testicular cancer is unusual; most others do not disappear. But there is growing evidence that cancers can go backward or stop, and researchers are being forced to reassess their notions of what cancer is and how it develops.
Of course, cancers do not routinely go away, and no one is suggesting that patients avoid treatment because of such occasional occurrences.
“Biologically, it is a rare phenomenon to have an advanced cancer go into remission,” said Dr. Martin Gleave, a professor of urology at the University of British Columbia.
But knowing more about how tumors develop and sometimes reverse course might help doctors decide which tumors can be left alone and which need to be treated, something that is now not known in most cases.
Cancer cells and precancerous cells are so common that nearly everyone by middle age or old age is riddled with them, said Thea Tlsty, a professor of pathology at the University of California, San Francisco. That was discovered in autopsy studies of people who died of other causes, with no idea that they had cancer cells or precancerous cells. They did not have large tumors or symptoms of cancer. “The really interesting question,” Dr. Tlsty said, “is not so much why do we get cancer as why don’t we get cancer?”
The earlier a cell is in its path toward an aggressive cancer, researchers say, the more likely it is to reverse course. So, for example, cells that are early precursors of cervical cancer are likely to revert. One study found that 60 percent of precancerous cervical cells, found with Pap tests, revert to normal within a year; 90 percent revert within three years.
And the dynamic process of cancer development appears to be the reason that screening for breast cancer or prostate cancer finds huge numbers of early cancers without a corresponding decline in late stage cancers.
If every one of those early cancers were destined to turn into an advanced cancer, then the total number of cancers should be the same after screening is introduced, but the increase in early cancers should be balanced by a decrease in advanced cancers.
That has not happened with screening for breast and prostate cancer. So the hypothesis is that many early cancers go nowhere. And, with breast cancer, there is indirect evidence that some actually disappear.
It is harder to document disappearing prostate cancers; researchers say they doubt it happens. Instead, they say, it seems as if many cancers start to grow then stop or grow very slowly, as has been shown in studies like one now being done at Johns Hopkins. When men have small tumors with cells that do not look terribly deranged, doctors at Johns Hopkins offer them an option of “active surveillance.” They can forgo having their prostates removed or destroyed and be followed with biopsies. If their cancer progresses, they can then have their prostates removed.
Almost no one agrees to such a plan. “Most men want it out,” Dr. Epstein said. But, still, the researchers have found about 450 men in the past four or five years who chose active surveillance. By contrast, 1,000 a year have their prostates removed at Johns Hopkins. From following those men who chose not to be treated, the investigators discovered that only about 20 percent to 30 percent of those small tumors progressed. And many that did progress still did not look particularly dangerous, although once the cancers started to grow the men had their prostates removed.
In Canada, researchers are doing a similar study with small kidney cancers, among the few cancers that are reported to regress occasionally, even when far advanced.
That was documented in a study, led by Dr. Gleave that compared an experimental treatment with a placebo in people with kidney cancer that had spread throughout their bodies.
As many as 6 percent who received a placebo had tumors that shrank or remained stable. The same thing happened in those who received the therapy, leading the researchers to conclude that the treatment did not improve outcomes.
The big unknown is the natural history of many small kidney tumors, many of which are early kidney cancers. How often do small tumors progress? Do they ever disappear? Do they all need surgical excision? At what stage do most kidney cancers reach a point of no return?
These days, Dr. Gleave said, more patients are having ultrasound or CT scans for other reasons and learning that there is a small lump on one of their kidneys. In the United States, the accepted practice is to take those tumors out. But, he asks, “Is that always necessary?”
His university is participating in a countrywide study of people with small kidney tumors, asking what happens when those tumors are routinely examined, with scans, to see if they grow. About 80 percent do not change or actually regress over the next three years.
With early detection, he said, “our net has become so fine that we are pulling in small fish as well as big fish.” Now, he said, “we have to identify which small fish we can let go.”
Product Description Superantioxidant From Brazil Acai is a palm from the Amazonian rainforest. It has small, purple fruits that have been used by Brazilian natives for food and health for hundreds of years. The active constituents in Acai are polyphenols and anthocyanins. Scientific studies have shown these compounds to be powerful antioxidants, benefiting the entire body by protecting the cells from free radicals…. More >> Acai Extract 500mg 60 Capsules
_thumb.jpg)
